Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Markets & Finance

Banc of America Cuts Biosite Rating

Banc of America downgraded Biosite Diagnostic (BSTE) to market perform from buy.

Analyst Ted Huber says the downgrade is based on the risk the company may lose access to antibody technology that is central to its Discovery and diagnostics business. He notes on Friday the company filed action against XOMA Ltd. seeking a court ruling that Biosites's three license agreements from XOMA remain valid. Huber says XOMA is seeking to renegotiate or terminate its license pacts with Biosite on the premise that Biosite is infringing on XOMA's patents.

blog comments powered by Disqus